InsiderTrades

Form 4 for ATYR aTYR PHARMA INC

Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001209191-23-031008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2023-05-19 2023-05-17 ATYR COUGHLIN TIMOTHY Dir G - Gift $0.00 +6,000 6,000 New $0
D 2023-05-19 2023-05-17 ATYR COUGHLIN TIMOTHY Dir G - Gift $0.00 -6,000 0 -100% $0
D 2023-05-19 2023-05-17 ATYR COUGHLIN TIMOTHY Dir A - Grant $0.00 +12.0K 12.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-17 G A 6,000 $0.00 6,000 I — —
2 Common Common Stock 2023-05-17 G D 6,000 $0.00 0 D See Footnote — — (F1) These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
3 Derivative Stock Option (right to buy) 2023-05-17 A A 12,000 $0.00 12,000 D $2.52 · — to 2033-05-17 12,000 Common Stock (F2) The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.